Randomized, Multicenter, Phase III Trial to Assess Conformal Post-operative Radiotherapy vs. Surveillance After Complete Resection of Stage II/III Thymoma (RADIO-RYTHMIC-01)

Abroad (travel likely)
Recruiting

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Thymoma Malignant Recurrent

Locations
  • CHU Caen, Caen, France
  • CLCC François BACLESSE, Caen, France
  • CLCC Georges François Leclerc, Dijon, France
  • Centre Oscar Lambret, Lille, France
  • CHU Lyon, Lyon, France
  • AP-HM Hôpital Nord, Marseille, France
  • Institut du Cancer de Montpellier, Montpellier, France
  • Antoine LACASSAGNE, Nice, France
  • Institut Curie, Paris, France
  • Hôpital Européen Georges Pompidou, Paris, France
  • Hôpital Bichat AP-HP, Paris, France
  • CHU Haut Lévêque, Pessac, France
  • CHU Rennes Hôpital Sud, Rennes, France
  • CHU Rouen, Rouen, France
  • CLCC Henri Becquerel, Rouen, France
  • Institut de Cancérologie de l'Ouest, Saint-Herblain, France
  • CHU Strasbourg, Strasbourg, France
  • Institut Claudius Regaud, Toulouse, France
  • CHRU Tours, Tours, France
  • Institut de Cancérologie de Lorraine Nancy, Vandœuvre-lès-Nancy, France
  • Gustave Roussy, Villejuif, France